Over the past decade, robotic neurorehabilitation has become one of the most discussed innovations in neurological recovery. Robotic gait trainers, upper-limb rehabilitation systems, exoskeletons, and AI-assisted rehabilitation devices are increasingly being adopted by hospitals and rehabilitation centres worldwide. However, an important question remains: Are robots the future of neurorehabilitation—or are they simply another tool in the rehabilitation toolbox? As clinicians and researchers, we must move beyond marketing claims and focus on scientific evidence, patient selection, and clinical reasoning. What is Robotic Neurorehabilitation? Robotic neurorehabilitation involves the use of electromechanical devices that assist, guide, resist, or augment movement during therapy. These technologies include: • Robotic gait trainers • Wearable exoskeletons • Upper limb robotic rehabilitation devices • End-effector robotic systems • Sensor-based rehabilitation platforms • AI-assiste...
Cell cycle
proteins, traditionally associated with regulating cell division and
proliferation, have been increasingly recognized for their novel functions in
post-mitotic neurons. Here are some key insights into the emerging roles of
cell cycle proteins in non-dividing neurons:
1. Regulation of
Neuronal Plasticity:
o Cyclins and
Cyclin-Dependent Kinases (CDKs): Cyclins and CDKs, known for their roles in cell cycle progression, have
been implicated in regulating neuronal plasticity and synaptic function in
post-mitotic neurons. These proteins can modulate synaptic strength, dendritic
spine morphology, and neurotransmitter release, influencing neuronal
connectivity and information processing [T42].
o Cell Cycle
Checkpoint Proteins: Proteins involved in cell cycle checkpoints, such as p53 and
retinoblastoma protein (Rb), have been shown to participate in neuronal
plasticity processes, including dendritic arborization, axonal growth, and
synapse formation. By integrating cellular stress signals, these proteins
contribute to the adaptive responses of neurons to environmental
cues [T43].
2. Maintenance of
Neuronal Homeostasis:
o Cell Cycle
Inhibitors: Cell
cycle inhibitors, such as p21 and p27, play roles beyond cell cycle regulation
in post-mitotic neurons. These proteins are involved in maintaining neuronal
homeostasis by controlling processes like apoptosis, DNA repair, and oxidative
stress response. Dysregulation of cell cycle inhibitors can lead to neuronal
dysfunction and neurodegeneration [T44].
o DNA Damage
Response Proteins: Components of the DNA damage response pathway, activated during cell
cycle checkpoints, have been identified as key players in neuronal survival and
function. These proteins help protect neurons from genotoxic stress, maintain
genomic integrity, and support neuronal longevity in the absence of cell
division [T45].
3. Implications for
Neurological Disorders:
o Neurodegenerative
Diseases:
Dysregulation of cell cycle proteins in post-mitotic neurons has been linked to
various neurodegenerative diseases, including Alzheimer's disease, Parkinson's
disease, and amyotrophic lateral sclerosis. Aberrant cell cycle re-entry,
impaired DNA repair mechanisms, and disrupted cell cycle protein expression
contribute to neuronal degeneration and disease progression [T46].
o Synaptopathies: Alterations in
cell cycle protein function have also been associated with synaptopathies,
disorders characterized by synaptic dysfunction and impaired neuronal
communication. By influencing synaptic plasticity, neurotransmission, and
synaptic maintenance, cell cycle proteins contribute to the pathophysiology of
synaptopathic conditions such as autism spectrum disorders and
schizophrenia [T47].
4. Therapeutic
Opportunities:
o Targeting Cell
Cycle Pathways: Modulating cell cycle pathways in post-mitotic neurons represents a
potential therapeutic strategy for neuroprotection and neuroregeneration in
various neurological disorders. By manipulating the activity of cell cycle
proteins, it may be possible to enhance neuronal resilience, promote synaptic
health, and mitigate disease-related neuronal damage [T48].
o Precision
Medicine Approaches: Precision medicine approaches that consider the specific roles of cell
cycle proteins in individual neurological conditions could lead to tailored
therapeutic interventions. By targeting the dysregulated cell cycle pathways
unique to each disorder, personalized treatment strategies may offer improved
outcomes for patients with neurodegenerative and synaptopathic
disorders [T49].
In conclusion,
the expanding understanding of cell cycle proteins in post-mitotic neurons
highlights their diverse functions in regulating neuronal plasticity,
maintaining homeostasis, and contributing to the pathogenesis of neurological
disorders. Exploring the therapeutic potential of targeting cell cycle pathways
in non-dividing neurons opens new avenues for developing innovative treatments
aimed at preserving neuronal function, enhancing synaptic connectivity, and
ultimately improving outcomes for individuals affected by neurological
conditions.
Comments
Post a Comment